Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-16-005293
Filing Date
2016-02-08
Accepted
2016-02-08 17:22:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 c83891_sc13g.htm SC 13G 75342
2 c83891_ex1.htm EX-1 3676
  Complete submission text file 0000930413-16-005293.txt   80584
Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G

Mailing Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102 (973) 242-0005
Neurotrope, Inc. (Subject) CIK: 0001513856 (see all company filings)

EIN.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88549 | Film No.: 161396483
SIC: 2834 Pharmaceutical Preparations